Market Value336,078,000
Total Holdings74
File Date2021-02-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
PHAS / PhaseBio Pharmaceuticals Inc
CGEN / Compugen Ltd.
CRDF / Cardiff Oncology, Inc.
DRNA / Dicerna Pharmaceuticals Inc
TBIO / Telesis Bio, Inc.
US750469AA69 / Radius Health, Inc. Bond
SCPH / scPharmaceuticals Inc.
US55027E1029 / Luminex Corporation
HOOK / HOOKIPA Pharma Inc.
US74140Y1010 / Prevail Therapeutics Inc.
AGTC / Applied Genetic Technologies Corp
RDUS / Radius Recycling, Inc.
SPPI / Spectrum Pharmaceuticals, Inc.
STIM / Neuronetics, Inc.
SIOX / Sio Gene Therapies Inc.
JNJ / Johnson & Johnson
GMTX / Gemini Therapeutics Inc
GMDA / Gamida Cell Ltd.
MDGL / Madrigal Pharmaceuticals, Inc.
ZYME / Zymeworks Inc.
/ Pandion Therapeutics Inc
/ Immunomedics, Inc.
US16706W1027 / Chiasma Inc
DMAC / DiaMedica Therapeutics Inc.
SAVA / Cassava Sciences, Inc.
NTUS / Natus Medical Inc
KDMN / Kadmon Holdings Inc
US2103731061 / Constellation Pharmaceuticals Inc
SAGE / Sage Therapeutics, Inc.
US0906721065 / BioTelemetry, Inc.
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
RCUS / Arcus Biosciences, Inc.
ATRC / AtriCure, Inc.
US00771VAB45 / Aerie Pharmaceuticals Inc
VERO / Venus Concept Inc.
MEIP / MEI Pharma, Inc.
GNFT / Genfit S.A.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
ALPN / Alpine Immune Sciences, Inc.
ARDX / Ardelyx, Inc.
ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock)
LQDA / Liquidia Corporation
AKBA / Akebia Therapeutics, Inc.
ARNA / Arena Pharmaceuticals Inc
AERI / Aerie Pharmaceuticals Inc
ASMB / Assembly Biosciences, Inc.
NXTC / NextCure, Inc.
ATHA / Athira Pharma, Inc.
KRTX / Karuna Therapeutics, Inc.
HARP / Harpoon Therapeutics, Inc.
ETNB / 89bio, Inc.
FATE / Fate Therapeutics, Inc.
INGN / Inogen, Inc.
MRSN / Mersana Therapeutics, Inc.
XENE / Xenon Pharmaceuticals Inc.
BPMC / Blueprint Medicines Corporation
KURA / Kura Oncology, Inc.
NBIX / Neurocrine Biosciences, Inc.
PRQR / ProQR Therapeutics N.V.
CSII / Cardiovascular Systems Inc.
APLS / Apellis Pharmaceuticals, Inc.
MORF / Morphic Holding, Inc.
OTIC / Otonomy Inc
BLUE / bluebird bio, Inc.
CARA / Cara Therapeutics, Inc.
KNTE / Kinnate Biopharma Inc.
ARCT / Arcturus Therapeutics Holdings Inc.
RVMD / Revolution Medicines, Inc.
STRO / Sutro Biopharma, Inc.
ACET / Adicet Bio, Inc.
IBB / iShares Trust - iShares Biotechnology ETF
AFMD / Affimed N.V.
BCRX / BioCryst Pharmaceuticals, Inc.
ISEE / IVERIC bio Inc
SCYX / SCYNEXIS, Inc.
MASI / Masimo Corporation
ARAY / Accuray Incorporated
KALV / KalVista Pharmaceuticals, Inc.
STXS / Stereotaxis, Inc.
SPRO / Spero Therapeutics, Inc.
IDYA / IDEAYA Biosciences, Inc.
DXCM / DexCom, Inc.
ALEC / Alector, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
BHVN / Biohaven Ltd.
LCTX / Lineage Cell Therapeutics, Inc.
VKTX / Viking Therapeutics, Inc.
LRMR / Larimar Therapeutics, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)